Article
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances.
Journal of clinical microbiology - 1 Apr 2012
Crudu Valeriu, Stratan Ecaterina, Romancenco Elena, Allerheiligen Vera, Hillemann Andreas, Moraru Nicolae
Abstract excerpt
The commercially available line probe assay MTBDRplus 2.0 (Hain Lifescience, Nehren, Germany) was evaluated for its ability to detect Mycobacterium tuberculosis complex (MTBC) and mutations conferring resistance to rifampin (RMP) and isoniazid (INH) directly in smear-negative and smear-positive p...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
